Last updated on November 2017

ACNS0334: A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 months old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue Versus the Same Therapy Without Methotrexate


Brief description of study

ACNS0334: A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 months old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue Versus the Same Therapy Without Methotrexate

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00336024?term=ACNS0334&rank=1

Clinical Study Identifier: TX1891

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Patricia Green

Memorial University Medical Center
Savannah, GA USA
  Connect »